Back to News & Events

Medisafe Secures $30M in Series C Funding to Build Future Model of Patient Support

Medisafe has raised $30 million in Series C funding with investments led by Sanofi Ventures and ALIVE Israel HealthTech Fund, joined by Leumi Partners, Menorah Mivtachim and Consensus Business Group, along with previous investors Pitango Ventures, 7Wire Ventures, Merck Ventures, Octopus Ventures, lool HealthTech, Triventures and Ourcrowd.

You may also like

Enhancing Multiple Sclerosis Patient Outcomes Through Digital Engagement

Multiple Sclerosis (MS) represents a formidable challenge in healthcare, a chronic, often unpredictable disease of the central nervous system that 

..Read More

Boosting Diabetes Adherence: Medisafe Digital Tools Deliver Results

Summary Managing diabetes presents significant challenges both for patients and pharmaceutical companies. Adherence to medication regimens, continuous monitoring, and lifestyle 

..Read More

High-Stakes GLP-1s: Where Digital Reinforcement Becomes Mission-Critical

Today’s groundbreaking announcement from Novo Nordisk and Eli Lilly to reduce the cost of their blockbuster weight loss drugs in 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.

Contact Us